It is considered that EGCG may be useful in the chemoprevention of breast carcinoma in which FAS over-expression results from signaling of human epidermal growth factor receptor 2 (HER2) or/and HER3, two members of EGFR family [32]. The gene discussed is ERBB2; the disease is breast carcinoma.